0B68 McGettigan, James P. - Thomas Jefferson University - Thomas Jefferson University
jpm001

James P. McGettigan, PhD

Contact Dr. McGettigan

1020 Locust Street
Jefferson Alumni Hall, Room 466
Philadelphia, PA 19107

(215) 503-4629
(215) 923-7144 fax

Most Recent Peer-reviewed Publications

  1. Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination
  2. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs
  3. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells In Vitro and enhanced antibody titers In-Vivo
  4. Reinvestigating the role of igM in rabies virus postexposure vaccination
  5. B cell infection and activation by rabies virus-based vaccines
  6. Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses
  7. Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity
  8. Experimental rabies vaccines for humans
  9. Characterization of a single-cycle rabies virus-based vaccine vector
  10. The cell biology of rabies virus: Using stealth to reach the brain
  11. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge
  12. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates
  13. Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity
  14. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
  15. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway
  16. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease
  17. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice
  18. Rabies virus glycoprotein as a carrier for anthrax protective antigen
  19. siRNA targeting Vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects
  20. Enhanced humoral HIV-1-specifc immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2
0